The first ImmunoPrecise Antibodies trade was made in Q2 2021. Since then Jim Simons bought shares six more times and sold shares on four occasions. The investor sold all their shares in Q3 2025 and doesn't own any shares in ImmunoPrecise Antibodies anymore.